Lack of Ultrastructural Detrusor Changes Following Endoscopic Injection of Botulinum Toxin Type A in Overactive Neurogenic Bladder von Haferkamp, A., Schurch, B., Reitz, A., Krengel, U., Grosse, J., Kramer, G., Schumacher, S., Bastian, P.J., Büttner, R., Müller, S.C., Stöhrer, M.

Volltext

Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks von Buchner, A, May, M, Burger, M, Bolenz, C, Herrmann, E, Fritsche, H.-M, Ellinger, J, Höfner, T, Nuhn, P, Gratzke, C, Brookman-May, S, Melchior, S, Peter, J, Moritz, R, Tilki, D, Gilfrich, C, Roigas, J, Zacharias, M, Hohenfellner, M, Haferkamp, A, Trojan, L, Wieland, W.F, Müller, S.C, Stief, C.G, Bastian, P.J

Volltext

Increased Expression of Connexin 43 in the Overactive Neurogenic Detrusor von Haferkamp, A., Mundhenk, J., Bastian, P.J., Reitz, A., Dörsam, J., Pannek, J., Schumacher, S., Schurch, B., Büttner, R., Müller, S.C.

Volltext

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the blad... von Nuhn, P, May, M, Fritsche, H.-M, Buchner, A, Brookman-May, S, Bolenz, C, Moritz, R, Herrmann, E, Burger, M, Höfner, T, Ellinger, J, Tilki, D, Roigas, J, Zacharias, M, Trojan, L, Wülfing, C, May, F, Melchior, S, Haferkamp, A, Gilfrich, C, Hohenfellner, M, Wieland, W.F, Müller, S.C, Stief, C.G, Bastian, P.J

Volltext

The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer von Tosco, Lorenzo, Laenen, A, Briganti, A, Gontero, P, Karnes, R.J, Albersen, Maarten, Bastian, P.J, Chlosta, P, Claessens, Frank, Chun, F.K, Everaerts, Wouter, Gratzke, C, Graefen, M, Kneitz, B, Marchioro, G, Salas, R.S, Tombal, B, Van den Broeck, T, Moris, Lisa, Battaglia, Antonino, van der Poel, H, Walz, J, Bossi, A, De Meerleer, Gert, Haustermans, Karin, Van Poppel, Hendrik, Spahn, M, Joniau, Steven

Volltext

516 Hospital but not surgical volume predicts 30- and 90-day complications in radical cystectomy (RC) – results from the prospective multicenter radical cystectomy series (PROMETRI... von Meyer, C.P, Leyh-Bannurah, S-R, Vetterlein, M.W, Mayr, R, Gierth, M, Fritsche, H-M, Burger, M, Keck, B, Wullich, B, Martini, T, Bolenz, C, Pycha, A, Hanske, J, Roghmann, F, Noldus, J, Gilfrich, C, Bastian, P.J, May, M, Rink, M, Chun, F.K.H, Dahlem, R, Fisch, M, Aziz, A

Volltext

Soy isoflavone genistein in prevention and treatment of prostate cancer von Perabo, F G E, Von Löw, E C, Ellinger, J, von Rücker, A, Müller, S C, Bastian, P J

Volltext

649 Risk-stratification for prediction of locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder von Aziz, A, Fröhner, M, May, M, Protzel, C, Hergenröther, K, Rink, M, Chun, F.K, Fisch, M, Roghmann, F, Palisaar, R-J, Noldus, J, Gierth, M, Fritsche, H-M, Burger, M, Sikic, D, Keck, B, Wullich, B, Nuhn, P, Buchner, A, Stief, C.G, Vallo, S, Bartsch, G, Haferkamp, A, Bastian, P.J, Hakenberg, O.W, Propping, S, Novotny, V

Volltext

446 PHOTOSELECTIVE LASER VAPORIZATION OF THE PROSTATE VERSUS TRANSURETHRAL PROSTATE RESECTION: A COST-BENEFIT ANALYSIS OF 1724 CASES von Gratzke, C, Krych, M, Reich, O, Bastian, P.J, Stief, C.G, Seitz, M

Volltext

510 QUANTIFICATION OF EPIGENETIC ALTERATIONS IN PROSTATE CANCER von Stadler, T.C, Jung, A, Schlenker, B, Boulesteix, A.L, Bernau, C, Buchner, A, Kirchner, T, Stief, C.G, Bastian, P.J

Volltext

Surgical outcome following radical nephrectomy in cases with inferior vena cava tumour thrombus extension von Bastian, P J, Haferkamp, A, Akbarov, I, Albers, P, Müller, S C

Volltext

603 Clinical nodal staging scores for bladder cancer: A proposal for preoperative risk-assessment von Rink, M, Ehdaie, B, Cha, E.K, Hansen, J, Svatek, R, Chromecki, T.F, Fajkovic, H, Novara, G, Daneshmand, S, Fradet, Y, Lotan, Y, Sagalowsky, A.I, Bastian, P.J, Kassouf, W, Fritsche, H.M, Burger, M, Izawa, J, Tilki, D, Abdollah, F, Chun, F.K, Sonpavde, G, Fisch, M, Scherr, D, Gonen, M, Shariat, S.F

Volltext

872 External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for muscle invasive urothelial c... von Fritsche, H.M, May, M, Burger, M, Nuhn, P, Otto, W, Buchner, A, Bolenz, C, Herrmann, E, Ellinger, J, Höfner, T, Tilki, D, Roigas, J, Zacharias, M, Trojan, L, Haferkamp, A, Gilfrich, C, Hertle, L, Hohenfellner, M, Müller, S.C, Stief, C.G, Wieland, W.F, Bastian, P.J

Volltext

775 Female gender is associated with worse cancer-specific survival after radical cystectomy for urothelial bladder carcinoma: Multicenter analysis of 2,483 patients von Otto, W, May, M, Fritsche, H.M, Bolenz, C, Trojan, L, Herrmann, E, Tiemann, A, Müller, S.C, Ellinger, J, Buchner, A, Stief, C.G, Tilki, D, Brookman-May, S, Denzinger, S, Wieland, W.F, Höfner, T, Hohenfellner, M, Haferkamp, A, Roigas, J, Zacharias, M, Bastian, P.J, Burger, M

Volltext

Primary extraskeletal osteosarcoma of the glans penis and glanular reconstruction von BASTIAN, P.J., SCHMIDT, M.E., VOGEL, J., STEINER, G., BASTIAN, H.‐P., MÜLLER, S.C.

Volltext

243 PREDICTION OF LOCALLY ADVANCED BLADDER CANCER BEFORE CYSTECTOMY AND OUTCOME ASSESSMENT OF PATIENTS WITH BLADDER CANCER AFTER CYSTECTOMY USING ARTIFICIAL NEURAL NETWORKS von Buchner, A, May, M, Bolenz, C, Herrmann, E, Höfner, T, Fritsche, H.M, Wülfing, C, Burger, M, Trojan, L, Tilki, D, Haferkamp, A, Michel, M.S, Ellinger, J, Gilfrich, C, Roigas, J, Hertle, L, Hohenfellner, M, Wieland, W.F, Müller, S.C, Bastian, P.J

Volltext

CELL-FREE DNA IN SERUM OF PATIENTS WITH BLADDER CANCER: DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS von Ellinger, J, Ellinger, N, Heukamp, L.C, Kahl, P, Perabo, F.G, Büttner, R, Müller, S.C, Von Ruecker, A, Bastian, P.J

Volltext

897 GLOBAL HISTONE MODIFICATIONS PREDICT BIOCHEMICAL RECURRENCE IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER von Ellinger, J, Von, Der Gathen J, Kahl, P, Gütgemann, I, Müller, S.C, Von, Rücker A, Bastian, P.J

Volltext

35 CONCOMITANT CARCINOMA IN SITU IS NOT ASSOCIATED WITH CLINICAL OUTCOMES AFTER RADICAL CYSTECTOMY von Nuhn, P, Bastian, P.J, Svatek, R.S, Karakiewicz, P.I, Skinner, E, Fradet, Y, Izawa, J.I, Kassouf, W, Novara, G, Montorsi, F, Fritsche, H.M, Tilki, D, Isbarn, H, Ficarra, V, Dinney, C.P, Shariat, S.F

Volltext

37 VALIDATION OF TUMOUR ARCHITECTURE IS AN INDEPENDENT PREDICTOR OF OUTCOMES AFTER RADICAL NEPHROURETERECTOMY von Fritsche, H.M, Novara, G, Gupta, A, Matsumoto, K, Kassouf, W, Walton, T, Burger, M, Tritschler, S, Baba, S, Bastian, P.J, Carballido, J, Seitz, C, Otto, W, Karakiewicz, P.I, Ficarra, V, Shariat, S.F

Volltext